Assessment of drugs in schizophrenia. Discussion on assessment of drug‐ induced extrapyramidal reactions.
- 1 June 1976
- journal article
- clinical trial
- Published by Wiley in British Journal of Clinical Pharmacology
- Vol. 3 (S2) , 401-403
- https://doi.org/10.1111/j.1365-2125.1976.tb03733.x
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Observations on the Dose Regime of Fluphenazine Decanoate in Maintenance Therapy of SchizophreniaThe British Journal of Psychiatry, 1975
- The Abrupt Withdrawal of Antiparkinsonian Drugs in Schizophrenic PatientsThe British Journal of Psychiatry, 1974
- Dopaminergic hypersensitivity and cholinergic hypofunction in the pathophysiology of tardive dyskinesiaPsychopharmacology, 1974
- The Side-Effects of Fluphenazine DecanoateThe British Journal of Psychiatry, 1973
- Comparison of amantadine, orphenadrine, and placebo in the control of phenothiazine-induced ParkinsonismPsychological Medicine, 1972
- Therapeutic Approaches to Tardive DyskinesiaArchives of General Psychiatry, 1972
- Evaluating the Long-Term Need for Antiparkinson Drugs by Chronic SchizophrenicsArchives of General Psychiatry, 1972
- Persistence of Extra-pyramidal Disorders and Psychiatric Relapse after Withdrawal of Long-Term Phenothiazine TherapyThe British Journal of Psychiatry, 1972
- Extrapyramidal Disorders After Prolonged Phenothiazine TherapyThe British Journal of Psychiatry, 1971
- A Survey of Drug-Induced Extrapyramidal ReactionsJAMA, 1961